Zuqiang Liu

1.6k total citations
38 papers, 1.2k citations indexed

About

Zuqiang Liu is a scholar working on Surgery, Gastroenterology and Oncology. According to data from OpenAlex, Zuqiang Liu has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 18 papers in Gastroenterology and 17 papers in Oncology. Recurrent topics in Zuqiang Liu's work include Pancreatic and Hepatic Oncology Research (14 papers), Esophageal and GI Pathology (12 papers) and Gastroesophageal reflux and treatments (11 papers). Zuqiang Liu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Esophageal and GI Pathology (12 papers) and Gastroesophageal reflux and treatments (11 papers). Zuqiang Liu collaborates with scholars based in China, United States and Ethiopia. Zuqiang Liu's co-authors include David L. Bartlett, Paweł Kaliński, Roshni Ravindranathan, Zong Sheng Guo, Xianjun Yu, Jiang Long, Guopei Luo, Chen Liu, Quanxing Ni and Jin Xu and has published in prestigious journals such as Nature Communications, International Journal of Molecular Sciences and The American Journal of Human Genetics.

In The Last Decade

Zuqiang Liu

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zuqiang Liu China 17 697 442 230 227 219 38 1.2k
João Subtil Spain 15 623 0.9× 332 0.8× 220 1.0× 68 0.3× 153 0.7× 61 1.1k
Olagunju Ogunbiyi United Kingdom 11 419 0.6× 373 0.8× 216 0.9× 55 0.2× 263 1.2× 18 1.2k
Kyosuke Tanaka Japan 19 313 0.4× 750 1.7× 119 0.5× 249 1.1× 118 0.5× 117 1.3k
Hyuk‐Chan Kwon South Korea 11 661 0.9× 297 0.7× 116 0.5× 190 0.8× 190 0.9× 17 1.2k
Martin Bolli Switzerland 18 515 0.7× 408 0.9× 629 2.7× 39 0.2× 335 1.5× 60 1.3k
Sadok Korbi Tunisia 20 439 0.6× 251 0.6× 85 0.4× 53 0.2× 366 1.7× 97 1.2k
Kazuya Sumi Japan 16 137 0.2× 563 1.3× 24 0.1× 503 2.2× 231 1.1× 58 953
Eleanor M. Scott United Kingdom 11 493 0.7× 126 0.3× 160 0.7× 99 0.4× 301 1.4× 12 946
Lori A. Kelly United States 15 214 0.3× 194 0.4× 81 0.4× 38 0.2× 575 2.6× 25 990
E. C. Sweeney Ireland 16 223 0.3× 288 0.7× 114 0.5× 50 0.2× 178 0.8× 46 881

Countries citing papers authored by Zuqiang Liu

Since Specialization
Citations

This map shows the geographic impact of Zuqiang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuqiang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuqiang Liu more than expected).

Fields of papers citing papers by Zuqiang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuqiang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuqiang Liu. The network helps show where Zuqiang Liu may publish in the future.

Co-authorship network of co-authors of Zuqiang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zuqiang Liu. A scholar is included among the top collaborators of Zuqiang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuqiang Liu. Zuqiang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Pingting, Chunman Zuo, Wei Yuan, et al.. (2025). Spatiotemporal multi-omics analysis uncovers NAD-dependent immunosuppressive niche triggering early gastric cancer. Signal Transduction and Targeted Therapy. 10(1). 313–313. 1 indexed citations
2.
Xu, Peirong, Zuqiang Liu, Li Wang, et al.. (2025). Free‐Hand Endoscopic Full‐Thickness Resection for Duodenal Subepithelial Lesions. Journal of Gastroenterology and Hepatology. 40(4). 907–916.
3.
Xu, Peirong, Zuqiang Liu, Jiyuan Zhang, et al.. (2024). Peroral endoscopic myotomy is an effective treatment for achalasia combined with hiatal hernia. Surgical Endoscopy. 38(8). 4543–4549.
4.
Liu, Zuqiang, Jiaqi Xu, Xiaoyue Xu, et al.. (2023). Imbalance of Innate and Adaptive Immunity in Esophageal Achalasia. Journal of Neurogastroenterology and Motility. 29(4). 486–500. 3 indexed citations
5.
Xu, Jiaqi, Zuqiang Liu, Yunshi Zhong, et al.. (2023). Landscape of Psychological Profiles in Patients With Esophageal Achalasia. Clinical and Translational Gastroenterology. 14(11). e00613–e00613.
6.
Chen, Weifeng, Pei‐Yao Fu, Jiaqi Xu, et al.. (2023). The role of type II esophageal microbiota in achalasia: Activation of macrophages and degeneration of myenteric neurons. Microbiological Research. 276. 127470–127470. 9 indexed citations
7.
Ma, Liyun, Zuqiang Liu, Weifeng Chen, Quan‐Lin Li, & Ping‐Hong Zhou. (2022). Transgastric Endoscopic Resection of a Superficial Pancreatic Tumor: The First Report in Human Beings. The American Journal of Gastroenterology. 117(3). 373–374. 2 indexed citations
8.
Li, Quan‐Lin, Weifeng Chen, Cheng Wang, et al.. (2021). Whole-exome sequencing reveals common and rare variants in immunologic and neurological genes implicated in achalasia. The American Journal of Human Genetics. 108(8). 1478–1487. 8 indexed citations
9.
Liu, Zuqiang, Yun Wang, Ying Fang, et al.. (2019). Short-term safety and efficacy of peroral endoscopic myotomy for the treatment of achalasia in children. Journal of Gastroenterology. 55(2). 159–168. 20 indexed citations
10.
Cheng, Jing, Weifeng Chen, Mei‐Dong Xu, et al.. (2019). Effect of peroral endoscopic myotomy in geriatric patients: a propensity score matching study. Surgical Endoscopy. 34(7). 2911–2917. 10 indexed citations
11.
Liu, Zuqiang, Xiaocen Zhang, Wei Zhang, et al.. (2017). Comprehensive Evaluation of the Learning Curve for Peroral Endoscopic Myotomy. Clinical Gastroenterology and Hepatology. 16(9). 1420–1426.e2. 59 indexed citations
12.
Liu, Zuqiang, Roshni Ravindranathan, Paweł Kaliński, Zong Sheng Guo, & David L. Bartlett. (2017). Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Nature Communications. 8(1). 14754–14754. 289 indexed citations
13.
Luo, Guopei, Chen Liu, Meng Guo, et al.. (2016). CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype. Cancer Letters. 385. 46–50. 20 indexed citations
14.
Luo, Guopei, Meng Guo, Kaizhou Jin, et al.. (2016). Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping. Pancreatology. 16(6). 1057–1062. 48 indexed citations
15.
Liu, Zuqiang, Kaizhou Jin, Meng Guo, et al.. (2016). Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer. Annals of Surgical Oncology. 24(2). 561–568. 137 indexed citations
16.
Liu, Chen, Lu Yu, Guopei Luo, et al.. (2016). Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?. Oncotarget. 7(20). 29177–29186. 9 indexed citations
18.
Luo, Guopei, Meng Guo, Zuqiang Liu, et al.. (2014). Blood Neutrophil–Lymphocyte Ratio Predicts Survival in Patients with Advanced Pancreatic Cancer Treated with Chemotherapy. Annals of Surgical Oncology. 22(2). 670–676. 130 indexed citations
19.
Luo, Guopei, Jiang Long, Xiaobo Cui, et al.. (2013). Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties. International Journal of Oncology. 42(3). 979–984. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026